Brinzolamide

Azopt

Carbonic Anhydrase Inhibitor

NADAC/unit $10.1642

No Shortage Tier 1: 13.4% 2 Manufacturers 2 ANDAs

AZOPT is a carbonic anhydrase inhibitor indicated in the treatment of elevated intraocular pressure (IOP) in patients with ocular hypertension or open-angle glaucoma.

vs. brand Azopt: Generic saves up to -2% per unit

Covered Lives

Generic Manufacturers

BAUSCH AND LOMB INCSANDOZ INCWATSON LABORATORIES INC

Explore in the Ecosystem

rxsaver.aiCompare prices for Brinzolamide drfinder.aiFind doctors who prescribe Brinzolamide clinicalrx.aiClinical profile: Brinzolamide rxnews.aiLatest news about Brinzolamide

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.